Holdings

Schwab Health Care Fund

As of Jul 31, 2026, Schwab Health Care Fund reported 80 positions worth US$636M. Largest: Eli Lilly and Company, Johnson & Johnson and AbbVie Inc. What it bought and sold, with each filing.

Holdings

Part of
Schwab
Positions
80
Value as reported
US$636M
Holdings as of
Jul 31, 2026
Last filed
Sep 24, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Eli Lilly and Company
NYSE:LLY
77,841US$89.4M13.9%−1,115Jul 31, 2026
Johnson & Johnson
NYSE:JNJ
174KUS$44.6M6.9%−19,021Jul 31, 2026
AbbVie Inc.
NYSE:ABBV
149KUS$37.3M5.8%−21,968Jul 31, 2026
Merck & Company, Inc.
NYSE:MRK
246KUS$32M5.0%no changeJul 31, 2026
UnitedHealth Group Incorporated
NYSE:UNH
73,427US$30.4M4.7%+11,143Jul 31, 2026
Gilead Sciences, Inc.
NASDAQ:GILD
160KUS$20.8M3.2%−24,628Jul 31, 2026
Novartis AG
SIX:NOVN
120KUS$18.8M2.9%−4,173Jul 31, 2026
Amgen Inc.
NASDAQ:AMGN
43,091US$16.6M2.6%−3,530Jul 31, 2026
Bristol-Myers Squibb Company
NYSE:BMY
240KUS$15.7M2.4%+119KJul 31, 2026
Medtronic plc.
NYSE:MDT
172KUS$14.7M2.3%−32,962Jul 31, 2026
Roche Holding Ltd
SIX:RO
33,618US$14.7M2.3%−2,291Jul 31, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
24,108US$13.8M2.2%no changeJul 31, 2026
Stryker Corporation
NYSE:SYK
41,586US$13.5M2.1%−9,684Jul 31, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
25,379US$12.1M1.9%+1,320Jul 31, 2026
GSK plc
LSE:GSK
427KUS$11.1M1.7%−74,774Jul 31, 2026
Boston Scientific Corporation
NYSE:BSX
220KUS$10.3M1.6%+25,393Jul 31, 2026
Abbott Laboratories
NYSE:ABT
97,408US$10.3M1.6%+29,077Jul 31, 2026
The Cigna Group
NYSE:CI
34,774US$9.7M1.5%−4,601Jul 31, 2026
Danaher Corporation
NYSE:DHR
48,332US$9.42M1.5%+13,445Jul 31, 2026
Elevance Health, Inc.
NYSE:ELV
24,845US$9.34M1.5%+21,172Jul 31, 2026
Incyte Corporation
NASDAQ:INCY
73,854US$8.83M1.4%+22,168Jul 31, 2026
Ipsen SA
EURONEXT:IPN
44,466US$8.59M1.3%+9,271Jul 31, 2026
Sanofi SA
EURONEXT:SAN
97,498US$8.4M1.3%+44,171Jul 31, 2026
Becton, Dickinson and Company
NYSE:BDX
48,036US$7.96M1.2%+4,160Jul 31, 2026
Astellas Pharma Inc.
TSE:4503
555KUS$7.63M1.2%−14,300Jul 31, 2026
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
29,378US$7.43M1.2%+23,003Jul 31, 2026
AstraZeneca PLC
LSE:AZN
42,820US$7.28M1.1%−19,578Jul 31, 2026
McKesson Corporation
NYSE:MCK
8,050US$6.89M1.1%−3,293Jul 31, 2026
STERIS plc (Ireland)
NYSE:STE
28,872US$6.59M1.0%−4,530Jul 31, 2026
IQVIA Holdings, Inc.
NYSE:IQV
27,860US$6.55M1.0%−6,181Jul 31, 2026
Cardinal Health, Inc.
NYSE:CAH
28,069US$6.46M1.0%−8,187Jul 31, 2026
HealthEquity, Inc.
NASDAQ:HQY
62,072US$6.25M0.97%−12,606Jul 31, 2026
CVS Health Corporation
NYSE:CVS
58,631US$6.12M0.95%newJul 31, 2026
Exelixis, Inc.
NASDAQ:EXEL
112KUS$5.92M0.92%−47,215Jul 31, 2026
United Therapeutics Corporation
NASDAQ:UTHR
11,322US$5.86M0.91%no changeJul 31, 2026
IDEXX Laboratories, Inc.
NASDAQ:IDXX
10,363US$5.79M0.90%+1,627Jul 31, 2026
ResMed Inc.
NYSE:RMD
25,092US$5.29M0.82%no changeJul 31, 2026
HCA Healthcare, Inc.
NYSE:HCA
12,961US$5.22M0.81%−6,027Jul 31, 2026
BrightSpring Health Services, Inc.
NASDAQ:BTSG
79,281US$4.73M0.74%−15,200Jul 31, 2026
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
6,059US$4.62M0.72%−8,884Jul 31, 2026
Koninklijke Philips N.V.
EURONEXT:PHIA
174KUS$4.59M0.71%+34,704Jul 31, 2026
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
26,394US$4.4M0.69%+20,194Jul 31, 2026
Veracyte, Inc.
NASDAQ:VCYT
87,202US$4.04M0.63%−26,963Jul 31, 2026
Agilent Technologies, Inc.
NYSE:A
27,455US$3.8M0.59%−15,000Jul 31, 2026
Hoya Corporation
TSE:7741
24,000US$3.67M0.57%−7,000Jul 31, 2026
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
43,420US$3.44M0.54%no changeJul 31, 2026
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
49,405US$2.97M0.46%+22,939Jul 31, 2026
Innoviva, Inc.
NASDAQ:INVA
132KUS$2.76M0.43%no changeJul 31, 2026
Axsome Therapeutics, Inc.
NASDAQ:AXSM
12,357US$2.69M0.42%+2,679Jul 31, 2026
Smith & Nephew plc
LSE:SN.
169KUS$2.64M0.41%−51,186Jul 31, 2026
Natera, Inc.
NASDAQ:NTRA
9,725US$2.6M0.41%−8,200Jul 31, 2026
Intuitive Surgical, Inc.
NASDAQ:ISRG
7,152US$2.53M0.39%no changeJul 31, 2026
Ascendis Pharma A/S
NASDAQ:ASND
9,761US$2.38M0.37%newJul 31, 2026
Align Technology, Inc.
NASDAQ:ALGN
13,600US$2.3M0.36%newJul 31, 2026
Novo Nordisk A/S Class B
OMXCOP:NOVO_B
45,699US$2.16M0.34%+15,846Jul 31, 2026
Asahi Intecc Co., Ltd.
TSE:7747
90,900US$2.05M0.32%+21,000Jul 31, 2026
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
176KUS$1.58M0.25%no changeJul 31, 2026
Ambea AB
OMXSTO:AMBEA
94,458US$1.43M0.22%no changeJul 31, 2026
Universal Health Services, Inc.
NYSE:UHS
8,100US$1.36M0.21%newJul 31, 2026
Krystal Biotech, Inc.
NASDAQ:KRYS
3,714US$1.27M0.20%newJul 31, 2026
Travere Therapeutics, Inc.
NASDAQ:TVTX
22,405US$1.25M0.19%newJul 31, 2026
Chugai Pharmaceutical Co., Ltd.
TSE:4519
28,000US$1.21M0.19%no changeJul 31, 2026
Pegavision Corp.
TWSE:6491
120KUS$1.19M0.19%newJul 31, 2026
Biogen Inc.
NASDAQ:BIIB
5,732US$1.16M0.18%−3,500Jul 31, 2026
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
75,100US$1.12M0.17%no changeJul 31, 2026
Fisher & Paykel Healthcare Corporation Limited
NZX:FPH
40,000US$957K0.15%−35,402Jul 31, 2026
Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX
50,864US$932K0.15%no changeJul 31, 2026
DexCom, Inc.
NASDAQ:DXCM
9,200US$768K0.12%newJul 31, 2026
Halozyme Therapeutics, Inc.
NASDAQ:HALO
8,998US$743K0.12%newJul 31, 2026
Liquidia Corporation
NASDAQ:LQDA
8,240US$693K0.11%newJul 31, 2026
Hikma Pharmaceuticals PLC
LSE:HIK
30,760US$657K0.10%newJul 31, 2026
AnaptysBio, Inc.
NASDAQ:ANAB
11,939US$637K0.10%no changeJul 31, 2026
Hugel, Inc.
KRX:145020
3,776US$609K0.09%no changeJul 31, 2026
Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
51,241US$414K0.06%no changeJul 31, 2026
Consun Pharmaceutical Group Ltd.
HKEX:1681
193KUS$337K0.05%−900KJul 31, 2026
Medipal Holdings Corporation
TSE:7459
17,900US$322K0.05%newJul 31, 2026
Attendo AB
OMXSTO:ATT
25,000US$288K0.04%newJul 31, 2026
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
2,435US$258K0.04%−12,300Jul 31, 2026
Elekta AB Class B
OMXSTO:EKTA_B
49,962US$254K0.04%no changeJul 31, 2026
GE HealthCare Technologies Inc.
NASDAQ:GEHC
2,800US$190K0.03%−148KJul 31, 2026